Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CP-4126 in Advanced Pancreatic Cancer
NCT00913198Phase 2Completed
- Sponsor
- Clavis Pharma
- Start
- Apr 2009
- Primary completion
- Jun 2011
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 2
01
Overview
A Phase 2 trial of elacytarabine in pancreatic cancer (PC), sponsored by Clavis Pharma. Started Apr 2009; status: completed.
02
Drugs
elacytarabine
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT00913198.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00913198.